The options for culturing cell therapies are vast from traditional T-flasks to novel bioreactors that didn't exist 5 years ago. The selection of the culture system during development can sometimes be done based on comfort with a particular system but, at commercial scale, that system may not be the best fit.

This presentation by Dan Swanson, Senior Process Engineer, lines out the current market place and the pros/cons of different systems.

More information and registration for INTERPHEX 2021 can be found here: https://www.interphex.com/